← Open Payments lookup

ELIZABETH AMOSS: Open Payments

NPI 1336845072 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$598 in 24 payments from 7 companies in 2025. Trend: 2023 $126 · 2024 $387 · 2025 $598

Food & beverage: $598
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.8$169
Janssen Pharmaceuticals, Inc4$154
ABBVIE INC.4$83
Alkermes, Inc.3$61
Neurocrine BioSciences, Inc.2$60
E.R. Squibb & Sons, L.L.C.2$44
Otsuka America Pharmaceutical, Inc.1$27

Products named: UZEDY, INVEGA SUSTENNA, VRAYLAR, INGREZZA, ARISTADA, COBENFY, ABILIFY ASIMTUFII, AUSTEDO XR.

Industry payments across MD — which companies pay providers there.